Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

42.86
Delayed Data
As of 3:59pm ET
 +0.18 / +0.42%
Today’s Change
37.59
Today|||52-Week Range
74.66
-20.73%
Year-to-Date

Today’s Trading

Previous close42.68
Today’s open42.74
Day’s range42.41 - 43.00
Volume1,953,702
Average volume (3 months)5,802,873
Market cap$21.7B
Dividend yield--
Data as of 3:59pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+14.57%
Earnings growth (next 5 years)+11.41%
Revenue growth (last year)+21.91%
P/E ratio18.5
Price/Sales2.84
Price/Book2.14

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-0.37-0.41%
ZTSZoetis Inc+0.33+0.70%
INCYIncyte Corp-1.38-1.66%
BMRNBiomarin Pharmaceuti...-1.55-1.75%
Data as of 4:01pm ET, 05/26/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$1.14
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts

Partner Offers

Search for Jobs